66
total announcements
543524.BO · 15 min delayed
Rainbow Children's Medicare Ltd
Rainbow Children's Medicare Ltd has executed definitive transaction documents for a new children and women's hospital at Malad, Mumbai, through its wholly owned subsidiary, involving an estimated project cost of ₹90 Crore. Fountainhead TCHM Healthcare LLP will acquire a 24% equity stake in the subsidiary, subject to terms and conditions.
Rainbow Children's Medicare Ltd
Rainbow Children's Medicare Ltd held its 28th Annual General Meeting on July 29, 2026, through video conferencing. The meeting approved the audited standalone financial statements for the FY ended March 31, 2026, and the audited consolidated financial statements for the FY ended March 31, 2026. The meeting also approved the declaration of a dividend of ₹ 3.5 per equity share for the FY ended March 31, 2026. A director, Dr. Adarsh Kancharla, was appointed in place of another director who retires by rotation.
Rainbow Children's Medicare Ltd
Rainbow Children's Medicare Ltd held its 28th Annual General Meeting on July 29, 2026, through video conference. The meeting was attended by the company's directors, key managerial personnel, and statutory auditors. The proceedings of the meeting have been attached to the announcement.
Rainbow Children's Medicare Ltd
Rainbow Children's Medicare Ltd has announced an earnings conference call to discuss its financial results for the quarter ended June 30, 2026. The call will be held on July 31, 2026, at 10:00 AM (IST) and will be attended by the company's management, including Dr. Ramesh Kancharla, Chairman and MD, and Mr. Vikas Maheshwari, Group Chief Financial Officer.
Rainbow Children's Medicare Ltd
Rainbow Children's Medicare Ltd has received an ESG rating of 61 and a Core ESG rating of 73 from CRISIL ESG, reflecting an improvement in its ESG rating compared to the previous year.
Rainbow Children's Medicare Ltd
Rainbow Children's Medicare Ltd has scheduled a board meeting on July 30, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.